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Objectives: To evaluate the prevalence of some virulence genes among 510 clinical Enterococ-
cus  spp. isolates and to assess the association of those genes with the species, infection site,
and  patient group (inpatients/outpatients).
Methods: Adhesins genes (aggregation substances agg and asa1 of Enterococcus faecalis and
Enterococcus faecium, respectively), enterococcal surface protein (esp), endocarditis-speciﬁc
antigen A (efaA), collagen-binding proteins (ace/acm)); invasins (hyaluronidase (hyl)  and
gelatinase (gelE)); cytotoxines (activation of cytolysin (cylA) in E. faecalis); and modulators of
the  host immunity and inﬂammation (enhanced expression pheromone (eep) in E. faecalis)
were  detected by polymerase chain reaction.
Results: The overall prevalence was: esp – 44.3%, agg/asa1 – 38.4%, ace/acm – 64.3%, efaA –
85.9%,  eep – 69.4%, gelE – 64.3%, hyl – 25.1%, and cylA – 47.1%. E. faecalis isolates had signiﬁ-
cantly higher frequency of adhesin genes (esp and agg/asa1) and gelatinase in comparison
to  E. faecium.  Multiple virulence genes in E. faecalis were signiﬁcantly more  prevalent than
in  E. faecium isolates. Domination of E. faecium with or without only one gene compared to
the  isolates of E. faecalis were found. Enterococcus spp. isolates obtained from outpatients
compared to inpatients isolates had signiﬁcantly higher frequency of agg/asa1, eep,  gelE and
cylA.  Some adhesins genes (esp, agg/asa1 and efaA) had higher prevalence among the non-invasive Enterococcus spp. isolates compared to those causing invasive bacteremia, while
er dissemination in isolates causing invasive infections compared toace/acm revealed highnon-invasive isolates.
Conclusion: Most E. faecalis attaches to abiotic surfaces in hospital environment, which cor-
relates with higher prevalence of gene encoding for virulence factors involved in bioﬁlm
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formation, such as enterococcal surface protein, aggregation substance, and gelatinase.
The  intestinal tract is an important reservoir for opportunistic enterococcal pathogens and
allows them to access infectious sites through different virulence factors, demonstrated in
outpatient isolates in this study.
©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-NDIntroduction
Enterococci (mostly Enterococcus faecalis and Enterococcus fae-
cium) are natural inhabitants of the gastrointestinal tract of
humans and animals,1 but are also found in other anatomi-
cal sites, including the vagina and oral cavity,2 and in the soil,
water, plants, and food.3–5 Several reports have documented
that the two most important species are among the leading
causes of opportunistic human infections,6 including uri-
nary tract infections,7 infections of the surgical site and burn
wound infections,8,9 bacteremia and sepsis,10 endocarditis,11
cholecystitis,12 peritonitis,13 neonatal meningitis,14 and oth-
ers.
The severe infections caused by Enterococcus spp. are dif-
ﬁcult to treat due to the organism’s capacity to survive in
the hospital environment, their intrinsic resistance to many
antimicrobials, their remarkable ability to acquire further
resistance mechanisms toward strategic antibiotics during the
treatment period and a variety of virulence factors.15
Virulence factors contribute to the pathogenesis of entero-
coccal infections through mediation of adhesion, colonization
and invasion into the host tissues, modulation of the host
immunity, and extracellular production of enzymes and tox-
ins, which enhance the severity of the infection.16 Many
virulence factors, such as the enterococcal surface pro-
tein (Esp), aggregation substance, capsule formation and
gelatinase, are involved in bacterial adherence to host cells
and/or in bioﬁlm formation on abiotic surfaces in hospi-
tal environment.17–21 Bioﬁlm production has an important
role in the pathogenesis of enterococcal infections and also
favors disease sustenance because of restricted penetration
of antimicrobials.19 Invasion is usually facilitated by damage
to host tissues and presence of virulence factors, including
hyaluronidase and gelatinase, which assist in the advance-
ment and further survival in newly  infected places.21
Currently, our knowledge about the possible relationship
between the presence of virulence factors and their implica-
tion in human enterococcal infections is still limited.
The aim of the present study was to examine the preva-
lence of genes encoding cell-associated and extracellular
virulence factors in clinically relevant isolates of Enterococ-
cus spp. and to assess the association of those genes with
species, infection site, and patient population (inpatients or
outpatients).
Materials  and  methodsBacterial  isolates
A collection of 510 non-duplicate clinical strains of Enterococ-
cus spp., causing symptomatic infections, was investigated. Alllicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
urinary tract infections were associated with signiﬁcant bac-
teriuria (≥105 CFU/mL). The isolates were recovered between
June 2013 and June 2015 from 398 inpatients and 112 outpa-
tients in seven large Bulgarian hospitals. They were obtained
from urine (n = 256), surgical wound or abscesses (n = 138), gen-
ital tract samples (n = 74), blood (n = 26), peritoneal ﬂuid (n = 6),
lower respiratory tract samples (n = 8), and bile (n = 2). E. faecalis
ATCC 29212 and E. faecium ATCC 19434 were used as control
strains for species identiﬁcation with biochemical and molec-
ular genetic techniques.
Culture  media
HiCrome E. faecium Agar Base (Himedia Labs) was applied to
isolate Enterococcus spp. strains. E. faecalis forms blue colonies,
while E. faecium gives green colonies, surrounded by yellowish
coloring of the ambient.
Biochemical  identiﬁcation  with  commercial  kits  and
systems
Species identiﬁcation was done using API Rapid ID 32 Strep
(bioMérieux), BBL Crystal Gram-positive ID kit (Becton Dickin-
son) and the automated system VITEK 2 (bioMérieux).
DNA  isolation
Total DNA from all used strains was extracted with GenEluteTM
Bacterial Genomic DNA Kit (Sigma–Aldrich), according to the
manufacturer’s instructions, from 3 mL  overnight cultures
inoculated with a single colony.
Molecular  genetic  genus  and  species  identiﬁcation
Polymerase chain reaction (PCR) ampliﬁcation of the 16S
rRNA gene of Enterococcus spp. was used for genus identiﬁ-
cation of all isolates included in this study. The sodA genes
encoding the enzyme manganese-dependent superoxide dis-
mutase in the most common enterococci (E. faecalis,  E. faecium
and Enterococcus durans)  were detected with multiplex PCR.
E. faecalis identiﬁcation was conﬁrmed by PCR for the eda1
gene (encoding 2-keto-3-deoxy-6-phosphogluconate aldolase,
which is an enzyme involved in the Entner–Doudoroff path-
way and is species-speciﬁc for E. faecalis). Oligonucleotides
used as primers and ampliﬁcation conditions were previously
described.22PCR  assay  for  detection  of  virulence  genes
PCR ampliﬁcation was performed in order to conﬁrm the pres-
ence of genes coding for different virulence factors: adhesins
 2 0 1 6;2 0(2):127–133 129
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Fig. 1 – Comparative frequency of virulence genes in E.
faecalis and E. faecium isolates. *Genes found only in E.
faecalis.b r a z j i n f e c t d i s .
aggregation substance – agg and asa1 of E. faecalis and E.
aecium, respectively), enterococcal surface protein (esp for
oth species), endocarditis-speciﬁc antigen A (efaA for both
pecies), collagen-binding proteins (ace/acm); invasins (extra-
ellular metalloendopeptidase also called gelatinase – gelE for
oth species, hyaluronidase – hyl for both species); cytotoxines
activation of cytolysin (class I. bacteriocin) – cylA in E. faecalis)
nd modulators of the host immunity and inﬂammation (sex
heromones – enhanced expression pheromone, eep in E. fae-
alis). Oligonucleotides used for speciﬁc ampliﬁcation primers
Alpha DNA) were previously published in the literature23–29
nd are shown in eTable 1 (see the E-supplemental material).
Supplementary Table 1 related to this article can be
ound, in the online version, at http://dx.doi.org/10.1016/
.bjid.2015.11.011.
PCR was carried out with 2 L template DNA, 0.25 M of
ach primer, 0.2 mM deoxyribonucleoside triphosphates, 1×
eaction buffer, 2 mM MgCl2 and 0.5 U Prime Taq DNA poly-
erase (Genet Bio) in a total volume of 25 L. The DNA
as ampliﬁed in Gene Pro Thermal Cycler (Bioer) using the
ollowing protocol: initial denaturation (94◦ C for 5 min), fol-
owed by 25–30 cycles of denaturation (94◦ C for 35–45 s),
nnealing (50–68◦ C, from 45 s to 1 min) and extension (72◦ C,
rom 45 s to 1 min  35 s), with a single ﬁnal extension of
 min  at 72◦ C. PCR products were separated in 1% agarose
el for 50–110 min  at 130 V, stained with ethidium bromide
0.5 g/mL) and detected by UV transillumination (wavelength
12 nm). Ampliﬁed genes were identiﬁed on the basis of frag-
ent size presented in eTable 1.
tatistical  analysis
he distribution of virulence genes with respect to both
pecies and isolate origin was compared using Student’s t-
est. For a simple comparison tests a p-value below 0.05 was
onsidered statistically signiﬁcant. In order to counteract the
roblem of multiple comparisons, when they were used, a
onferroni correction with a critical value of p = 0.00625 was
pplied.
esults
revalence  of  virulence  genes  among  all  studied
nterococcus  spp.  isolates  (n  =  510)
he established overall frequencies of the studied
enes encoding adhesins (esp, agg/asa1, ace/acm, efaA),
Table 1A – Virulence potential (depending the number of presen
different infection sites.
Number of virulence genes Number (%) of i
Urine (n = 176) Wounds (n = 96) Genita
0 0 (0.0) 0 (0.0) 0
1 0 (0.0) 2 (2.1) 0
2–4 42 (23.9) 28 (29.2) 18
5–7 124 (70.5) 64 (66.7) 48
8 10 (5.7) 2 (2.1) 4
a Genital tract specimens – sperm, urethral, vaginal and cervical samples
b Others – peritoneal ﬂuid (n = 4), bile (n = 2) and lower respiratory tract sammodulators of the host immunity and inﬂammation (eep),
invasins (gelE, hyl), and cytotoxins (cylA) were as it fol-
lows: 44.3%, 38.4%, 64.3%, 85.9%, 69.4%, 64.3%, 25.1%, and
47.1%.
Comparative  prevalence  of  virulence  genes  among  E.
faecalis  (n  =  370)  and  E.  faecium  (n  =  110)
The prevalence of virulence genes in the two  species was
esp – 59.5% in E. faecalis and 4.3% in E. faecium (p < 0.001),
agg/asa1 – 44.3% vs. 22.8% (p < 0.001), ace/acm – 61.1%/72.8%,
efaA – 84.9%/88.5%, gelE – 82.2%/17.1% (p < 0.001), and hyl –
25.3%/24.2%. eep was found in 95.7% of E. faecalis isolates and
cylA in 64.9% (Fig. 1).
The genes associated with virulence potential of the
studied E. faecalis and E. faecium isolates are shown in
Tables 1A and 1B. It should be pointed out in these tables the
signiﬁcantly higher prevalence of E. faecalis with multiple vir-
ulence determinants (over 4) compared to E. faecium (71.9%
vs. 1.5%, p < 0.001), whereas isolates with only one determi-
nant signiﬁcantly prevailed in E. faecium compared to E. faecalis
(50.0%/1.1%, p < 0.001).
t virulence factor genes) in 370 E. faecalis isolates from
solates with the respective number of genes
l tracta (n = 70) Blood (n = 18) Others b (n = 10) Total (n = 370)
 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 (0.0) 0 (0.0) 2 (20.0) 4 (1.1)
 (25.7) 10 (55.6) 2 (20.0) 100 (27.0)
 (68.6) 6 (33.3) 6 (60.0) 248 (67.0)
 (5.7) 2 (11.1) 0 (0.0) 18 (4.9)
.
ples (n = 4).
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Table 1B – Virulence potential (depending the number of present virulence factor genes) in 140 E. faecium isolates from
different infection sites.
Number of virulence genes Number (%) of isolates with the respective number of genes
Urine (n = 80) Wounds (n = 42) Genital tracta (n = 4) Blood (n = 8) Othersb (n = 6) Total (n = 140)
0 12 (15) 2 (4.8) 0 (0) 0 (0) 0 (0) 14 (10)
1 30 (37.5) 14 (33.4) 0 (0) 6 (75) 6 (100) 56 (40)
2–4 38 (47.5) 24 (57.2) 4 (100) 2 (25) 0 (0) 68 (48.6)
5 0 (0) 2 (4.8) 0 (0) 0 (0) 0 (0) 2 (1.4)
es (n =
 (n = 4
pared to our isolates (26.4%/64.9%, p < 0.001), and close to our
distribution of esp, agg, ace and efaA (52.7%/59.5%; 42.8%/44.3%;
67%/61.1%; 96.7%/84.9%).32
0%
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agg/asa1
ace/acm
efaA
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geIE
hyl
cylA*a Genital tract specimens – sperm samples (n = 2) and vaginal sampl
b Others – peritoneal ﬂuid (n = 2) and lower respiratory tract samples
Comparative  prevalence  of  virulence  genes  in  Enterococcus
spp. with  respect  to  the  infection  site
Table 2 lists the prevalence of virulence genes of all enterococci
isolates, as well as the prevalence in each enterococcal species,
broken down  by the infection site. The following are the most
important results found:
• The genes for some adhesins (esp; agg/asa1 and efaA) were
signiﬁcantly more  prevalent among the non-invasive iso-
lates of Enterococcus spp. (51.4% in genital tract infection
(GTI) isolates, 39.1–59.5% in wound and GTI isolates, and
93.8% in urinary tract infection (UTI) isolates) compared to
the invasive bacteremia isolates (respectively, 23.1%, 15.4%,
and 61.5%) (p < 0.001–0.05), while ace/acm revealed a signif-
icantly higher frequency (p < 0.02–0.05) in invasive isolates
(84.6%) compared to the non-invasive GTI and wound iso-
lates (54.1% and 59.4%, respectively).
• For E. faecalis,  agg was more  frequent in isolates from the
genital tract (57.1%) in comparison to the isolates from blood
(22.2%) – p < 0.05, while efaA was more  common in isolates
from UTI (94.3%) vs. from wound samples (72.9%) – p < 0.01.
• For E. faecium, there were no signiﬁcant differences in the
distributions of genes encoding virulence factors, according
to the infection site, but isolates from blood stream infec-
tions (n = 8) were not considered due to their low number.
Comparative  prevalence  of  virulence  genes  among
Enterococcus  spp.  isolates  obtained  from  inpatients
(n =  398)  and  outpatients  (n  =  112)  with  symptomatic
infections
Enterococcus spp. isolates from outpatients had signiﬁcantly
higher prevalence (p < 0.001–0.02) of the following virulence
genes compared to the isolates from inpatients: agg/asa1
(58.9%/32.7%), eep (92.9%/62.8%), gelE (78.6%/60.3%), and cylA
(73.2%/37.9%) – Fig. 2.
Discussion
In this study, we  found a signiﬁcantly higher prevalence
(p < 0.001) of genes encoding some virulence factors involved
in bioﬁlm formation (the enterococcal surface protein (esp),
aggregation substance (agg) and gelatinase (gelE)) in E. fae-
calis, compared to E. faecium. A previous study indicated higher
prevalence of bioﬁlm formation among E. faecalis strains 2).
).
compared to other enterococcal species.30 E. faecalis has been
recognized as the enterococcal species most commonly infect-
ing indwelling medical devices.17,30 In a study conducted by
Dupré et al. with clinically relevant enterococcal isolates from
a hospital in Sardinia, Italy, in the period of 1998–2001 there
was a complete absence of genes for gelatinase and aggre-
gation substance in E. faecium, but contrary to our results,
higher frequency of esp in E. faecium vs. E. faecalis was reported
(71.9%/60%).23
The prevalence of efaA, eep, gelE, and cylA in E. faecalis iso-
lates in our study was signiﬁcantly higher than previously
published data on clinical strains of E. faecalis from Brazil in
2004 – as it follows: 84.9%/58.9%; 95.7%/58.9%; 82.2%/45.3%;
64.9%/16.8% (p < 0.001), while the gene frequency for agg
and esp had similar rates in both studies (44.3%/36.8%, and
59.5%/57.9%).29 Detection of genes for adhesins (esp, agg, ace
and efaA) in newer clinical E. faecalis isolates from South-
ern Brazil was more  frequent than the rates found in our
study (respectively, 68.4% in Brazil vs. 59.5% in our study,
57.9%/44.3%, 73.7%/61.1% and 100%/84.9%). In contrast, genes
for gelE and cylA were more  frequent in our isolates than
among the Brazilian isolates (77.2%/82.2% and 54.4%/64.9%,
respectively).31 A recent study of clinical isolates of E. faecalis
in Italy showed a signiﬁcantly lower frequency of cylA com-Fig. 2 – Comparative frequency of virulence genes in
Enterococcus spp. isolates, causing symptomatic infections
in inpatients and outpatients. *Genes found only in E.
faecalis.
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Table 2 – Prevalence of virulence genes in 510 clinical Enterococcus spp. (370 E. faecalis and 140 E. faecium) isolates
according to the site of infection.
Gene Number  (%) of isolates with the respective gene
Urine Wounds Genital tracta Blood Othersb Total
(nFL = 176)
(nFM = 80)
(n = 256)
(nFL = 96)
(nFM = 42)
(n = 138)
(nFL = 70)
(nFM = 4)
(n = 74)
(nFL = 18)
(nFM = 8)
(n = 26)
(nFL = 10)
(nFM = 6)
(n = 16)
(nFL = 370)
(nFM = 140)
(n = 510)
esp-FL  114 (64.8) 58 (60.4) 38 (54.3) 6 (33.3) 4 (40.0) 220 (59.5)
esp-FM 2 (2.5) 4 (9.5) 0 (0) 0 (0) 0 (0) 6 (22.8)
esp-FL + esp-FM 116 (45.3) 62 (44.9) 38 (51.4) 6 (23.1) 4 (25.0) 226 (44.3)
agg 76 (43.2) 42 (43.8) 40 (57.1) 4 (22.2) 2 (20.0) 164 (44.3)
asa1 16 (20.0) 12 (28.6) 4 (100) 0 (0) 0 (0) 32 (22.8)
agg + asa1 92 (36.0) 54 (39.1) 44 (59.5) 4 (15.4) 2 (12.5) 196 (38.5)
ace 114 (64.8) 52 (54.2) 38 (54.3) 14 (77.8) 8 (80.0) 226 (61.1)
acm 56 (70.0) 30 (71.4) 2 (50.0) 8 (100) 6 (100) 102 (72.8)
ace + acm 170 (66.4) 82 (59.4) 40 (54.1) 22 (84.6) 14 (87.5) 328 (64.3)
efaA-FL 166 (94.3) 70 (72.9) 58 (82.9) 12 (66.7) 8 (80.0) 314 (84.9)
efaA-FM 74 (92.5) 36 (85.7) 4 (100) 4 (50.0) 6 (100) 124 (88.5)
efaA-FL + efaA-FM 240  (93.8) 106 (76.8) 62 (83.8) 16 (61.5) 14 (87.6) 438 (85.9)
eep-FL 174 (98.9) 90 (93.8) 66 (94.3) 16 (88.9) 8 (80.0) 354 (95.7)
eep-FM N/A N/A N/A N/A N/A N/A
gelE-FL 146 (83.0) 78 (81.3) 58 (82.9) 14 (77.8) 8 (80.0) 304 (82.2)
gelE-FM 12 (15.0) 10 (23.8) 2 (50.0) 0 (0) 0 (0) 24 (17.1)
gelE-FL + gelE-FM 158 (61.7) 88 (63.7) 60 (81.1) 14 (53.8) 8 (50.0) 328 (64.3)
hyl-FL 48 (27.3) 22 (22.9) 20 (28.6) 4 (22.2) 0 (0) 94 (25.3)
hyl-FM 22 (27.5) 8 (19.0) 2 (50) 2 (25.0) 0 (0) 34 (24.2)
hyl-FL + hyl-FM 70 (27.3) 30 (21.7) 22 (29.7) 6 (23.1) 0 (0) 128 (25.1)
cylA-FL 110 (62.5) 62 (64.6) 54 (77.1) 8 (44.4) 6 (60.0) 240 (64.9)
cylA-FM N/A N/A N/A N/A N/A N/A
FL, E. faecalis; FM, E. faecium; N/A, not applicable for E. faecium. esp,  gene for enterococcal surface protein (adhesin) for both species; agg,  E.
faecalis aggregation substance involved in adherence to mammalian cells and conjugation; asa1, E. faecium aggregation substance involved in
adherence to mammalian cells and conjugation; ace,  E. faecalis Ace collagen-binding protein (adhesin); acm,  E. faecium Acm collagen-binding
protein (adhesin); efaA,  cell wall adhesin expressed in patient serum (endocarditis-speciﬁc antigen A) for both species; eep (enhanced expression
of pheromone), membrane protein of E. faecalis; gelE,  extracellular metalloendopeptidase (gelatinase) for both species; hyl,  hyaluronidase for
both species; cylA,  activation of cytolysin (hemolysin/class I. bacteriocin) of E. faecalis.
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b others – peritoneal ﬂuid (n = 6), bile (n = 2) and lower respiratory tra
A multicenter study on the distribution of virulence deter-
inants in fecal E. faecium isolates from patients in 13
ospitals from nine European countries showed total absence
f asa1 and gelE, lower frequency of hyl in comparison to E. fae-
ium isolates (17%/24.2%) of our study and signiﬁcantly higher
revalence of esp (65% vs. 4.3%, p < 0.001).26
The signiﬁcantly higher prevalence of clinical E. faecalis
solates with multiple virulence determinants (over 4) com-
ared to E. faecium, and the signiﬁcant predominance of E.
aecium isolates with one gene compared to E. faecalis, demon-
trated in this study, was also recently found by Padmasini
t al.33 According to another study of enteroccoci from clini-
al isolates and starter cultures, all strains of E. faecalis were
haracterized by a high number of virulence genes (between
 and 11), while the E. faecium strains had no such gene
eterminants.25
In Italy, Creti et al. reported wider distribution of esp in
on-invasive E. faecalis isolates (56.2%) compared to invasive
solates (38.4%).28 In our study esp was found in 33.3% of infec-
ions caused by E. faecalis, with bacteremia in the clinical
ourse, while the frequency of esp in non-invasive infections
aried from 54.3% (in GTIs) to 64.8% (in UTIs), which conﬁrms
he important role of Esp as a colonizing factor in UTIs.34 The.
ples (n = 8).
frequency of esp among our UTI E. faecalis isolates (64.8%) was
very similar to the rate reported by Creti et al. (66.7%). The
ﬁndings for cylA in both studies were similar: 44.4% in inva-
sive isolates from bacteremia in our data vs. 50% in the Italian
study, as well as the results for cylA in non-invasive isolates
– varying from 62.5% to 77.1% in our study and 62.5% in the
Italian study.28
Recently Padilla et al. published their data on incidence of
virulence genes amongst strains of E. faecalis isolated from
UTIs and bacteremia in Chile, for the period of 2008–2009.35
The rates for the following genes from urine samples in
our study were signiﬁcantly higher than those reported in
Chile: efaA (94.3%/62%, p < 0.001), eep (98.9%/72%, p < 0.001), gelE
(83%/28%, p < 0.001), cylA (62.5%/40%, p < 0.01); while the pres-
ence of agg was signiﬁcantly lower (43.2%/78%, p < 0.001). Our
isolates from bacteremia showed a signiﬁcantly higher fre-
quency of efaA compared to the Chilean isolates (66.7%/28%,
p < 0.001).
E. faecalis isolates from patients with UTIs and wound
infections in the present study showed higher prevalence of
numerous virulence genes, compared to similar isolates from
Brazil, studied by Bittencourt de Marques and Suzart – esp
(64.9% and 60.4% vs. 62% and 46.1%), agg (43.2% and 43.8%/38%
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and 38.5%), efaA (94.3% (p < 0.001) and 72.9%/54% and 69.2%),
eep (98.9% (p < 0.001) and 93.8% (p < 0.001)/58% and 53.8%), gelE
(83% (p < 0.001) and 81.3% (p < 0.001)/50% and 34.6%) and cylA
(62.5% (p < 0.001) and 64.6% (p < 0.001)/22% and 3.8%).29
An interesting ﬁnding from the present study was the
higher dissemination rates of gene determinants for some
virulence factors among Enterococcus spp. causing infections
in outpatients, compared to those infecting inpatients. The
review of published medical literature could not ﬁnd a similar
comparative study. Hospitalized patients may have a greater
incidence of enterococcal infections not only because of vir-
ulence, but because the hospital itself is a risky hub. On the
other hand, the intestinal tract is an important reservoir for
opportunistic pathogens such as enterococci and allows them
to access infected sites especially in outpatients through dif-
ferent virulence factors.21 A weakness of this comparative
analysis results from the difﬁculties to obtain epidemiological
data; often UTIs, occurring in inpatients, begin before admis-
sion to the hospital.
Conclusions
In the present study clinical E. faecalis isolates were charac-
terized by a signiﬁcantly higher frequency of genes encoding
some adhesins and gelatinase in comparison to E. faecium
isolates. The higher virulence potential of E. faecalis vs. E. fae-
cium isolates was proven (on the basis of a signiﬁcantly higher
prevalence of E. faecalis isolates with multiple virulence factor
genes vs. E. faecium and signiﬁcant predominance of E. fae-
cium isolates without or with only one gene compared to the
E. faecalis).
The genes for some adhesins (esp and agg/asa1) were more
prevalent in non-invasive Enterococcus spp. isolates than in
invasive isolates from bacteremia, while ace/acm showed a
signiﬁcantly higher frequency among invasive isolates.
For the ﬁrst time, we  proved that Enterococcus spp. isolates
from outpatients with symptomatic infections had signif-
icantly higher frequency of the following virulence genes:
agg/asa1, eep, gelE and cylA, in comparison to isolates causing
infections in inpatients.
To the best of our knowledge, this is the ﬁrst study in Bul-
garia and in the Balkans region of the genes associated cellular
and extracellular virulence factors among clinically relevant
Enterococcus spp. isolates, in which a comparative analysis with
respect to different features (species of microorganism, infec-
tion site, and origin) was made. Our results may serve as a
basis for additional research of the pathogenesis of infections
caused by Enterococcus spp.
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